Yeow Tee Goh

3.8k total citations
101 papers, 932 citations indexed

About

Yeow Tee Goh is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Yeow Tee Goh has authored 101 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Hematology, 43 papers in Genetics and 22 papers in Oncology. Recurrent topics in Yeow Tee Goh's work include Chronic Myeloid Leukemia Treatments (34 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers). Yeow Tee Goh is often cited by papers focused on Chronic Myeloid Leukemia Treatments (34 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers). Yeow Tee Goh collaborates with scholars based in Singapore, United States and South Korea. Yeow Tee Goh's co-authors include William Ying Khee Hwang, Yeh Ching Linn, Andreas Hochhaus, Jörge E. Cortes, Daryl Tan, Liang Piu Koh, Hervé Dombret, M. Brigid Bradley‐Garelik, Tamás Masszi and Giuseppe Saglio and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yeow Tee Goh

93 papers receiving 909 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yeow Tee Goh Singapore	16	501	367	243	218	199	101	932
Claudia Baratè Italy	19	513 1.0×	499 1.4×	225 0.9×	190 0.9×	127 0.6×	56	1.0k
Paola Masolini Italy	17	389 0.8×	187 0.5×	252 1.0×	294 1.3×	157 0.8×	24	849
Vamsi Kota United States	19	887 1.8×	397 1.1×	397 1.6×	408 1.9×	126 0.6×	156	1.4k
Frank Giles United States	15	504 1.0×	352 1.0×	335 1.4×	188 0.9×	171 0.9×	68	912
Yeo‐Kyeoung Kim South Korea	20	675 1.3×	253 0.7×	412 1.7×	261 1.2×	243 1.2×	91	1.2k
Yoshihiro Kameoka Japan	17	294 0.6×	270 0.7×	563 2.3×	330 1.5×	220 1.1×	64	1.3k
Naresh Punwani United States	12	268 0.5×	288 0.8×	178 0.7×	241 1.1×	224 1.1×	17	803
Éliane Duchayne France	18	701 1.4×	470 1.3×	312 1.3×	241 1.1×	204 1.0×	38	1.2k
Christophe Willekens France	18	453 0.9×	255 0.7×	375 1.5×	186 0.9×	162 0.8×	50	946
Pierluigi Rossi Ferrini Italy	18	655 1.3×	458 1.2×	341 1.4×	168 0.8×	78 0.4×	56	1.1k

Countries citing papers authored by Yeow Tee Goh

Since Specialization

Citations

This map shows the geographic impact of Yeow Tee Goh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeow Tee Goh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeow Tee Goh more than expected).

Fields of papers citing papers by Yeow Tee Goh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yeow Tee Goh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeow Tee Goh. The network helps show where Yeow Tee Goh may publish in the future.

Co-authorship network of co-authors of Yeow Tee Goh

This figure shows the co-authorship network connecting the top 25 collaborators of Yeow Tee Goh. A scholar is included among the top collaborators of Yeow Tee Goh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yeow Tee Goh. Yeow Tee Goh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ueda, Yasutaka, Wen‐Chien Chou, Yeow Tee Goh, et al.. (2025). Prevention and Management of Thromboembolism in Patients with Paroxysmal Nocturnal Hemoglobinuria in Asia: A Narrative Review. International Journal of Molecular Sciences. 26(6). 2504–2504. 1 indexed citations

Lim, Nicole-Ann, Yang Sun, Jing Yuan Tan, et al.. (2025). Outcomes in relapsed/refractory diffuse large B-cell lymphoma in an Asian tertiary cancer center: real-world interventions as benchmark for novel therapy. SHILAP Revista de lepidopterología. 10. 100195–100195.

Cortes, Jörge E., Fabian Lang, Delphine Réa, et al.. (2025). Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results. Leukemia. 39(5). 1124–1134. 4 indexed citations

Ding, Ling‐Wen, Jia Li, Benedict Yan, et al.. (2024). A Pre-Leukemic DNA Methylation Signature in Healthy Individuals at Higher Risk for Developing Myeloid Malignancy. Clinical Cancer Research. 30(10). 2170–2180. 1 indexed citations

Than, Hein, et al.. (2024). Fusion Genes in Myeloid Malignancies. Cancers. 16(23). 4055–4055.

Hughes, Timothy P., Andreas Hochhaus, Naoto Takahashi, et al.. (2024). ASC4FIRST, a pivotal phase 3 study of asciminib (ASC) vs investigator-selected tyrosine kinase inhibitors (IS TKIs) in newly diagnosed patients (pts) with chronic myeloid leukemia (CML): Primary results.. Journal of Clinical Oncology. 42(17_suppl). LBA6500–LBA6500. 2 indexed citations

Wong, Raymond, Jun Ho Jang, Jin Seok Kim, et al.. (2024). Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus. International Journal of Molecular Sciences. 25(22). 12160–12160.

Aoki, Naomi, Wenming Chen, Wee Joo Chng, et al.. (2024). The establishment of a multiple myeloma clinical registry in the Asia–Pacific region: The Asia–Pacific Myeloma and Related Diseases Registry (APAC MRDR). BMC Medical Research Methodology. 24(1). 102–102.

Harrison, Claire, Ruben A. Mesa, Moshe Talpaz, et al.. (2024). Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor–Naive or –Experienced Myelofibrosis Treated With Momelotinib. Clinical Lymphoma Myeloma & Leukemia. 25(3). 199–211. 2 indexed citations

10.

Tan, Kar Wai, Xiubo Fan, Zhiyong Poon, et al.. (2023). Cord blood–derived V _δ 2 ⁺ and V _δ 2 ⁻ T cells acquire differential cell state compositions upon in vitro expansion. Science Advances. 9(24). eadf3120–eadf3120. 7 indexed citations

11.

Chuncharunee, Suporn, Yok‐Lam Kwong, Andrew H. Wei, et al.. (2023). Asia‐Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia‐Pacific region. Asia-Pacific Journal of Clinical Oncology. 19(6). 655–663. 1 indexed citations

12.

Chen, Yunxin, Melissa Ooi, Sanjay De Mel, et al.. (2023). AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management. Annals of the Academy of Medicine Singapore. 52(11). 601–624. 2 indexed citations

13.

Wong, Raymond, Yeow Tee Goh, David Gómez‐Almaguer, et al.. (2023). Pegcetacoplan controls hemolysis in complement inhibitor–naive patients with paroxysmal nocturnal hemoglobinuria. Blood Advances. 7(11). 2468–2478. 32 indexed citations

14.

Gerds, Aaron T., Srđan Verstovšek, Alessandro M. Vannucchi, et al.. (2022). Thrombocytopenic myelofibrosis (MF) patients previously treated with a JAK inhibitor in a phase 3 randomized study of momelotinib (MMB) versus danazol (DAN) [MOMENTUM].. Journal of Clinical Oncology. 40(16_suppl). 7061–7061. 5 indexed citations

15.

Nagarajan, Chandramouli, Nicholas F. Grigoropoulos, S. Gopalakrishnan, et al.. (2017). VALIDATION OF THE CNS INTERNATIONAL PROGNOSTIC INDEX IN A LARGE ASIAN COHORT–DATA FROM THE SINGAPORE LYMPHOMA STUDY GROUP. Hematological Oncology. 35(S2). 197–198. 1 indexed citations

16.

Tan, Daryl, Kiat Hoe Ong, Liang Piu Koh, et al.. (2012). The impact of frontline risk‐adapted strategy on the overall survival of patients with newly diagnosed multiple myeloma: an analysis of the Singapore multiple myeloma study group. European Journal Of Haematology. 89(2). 136–144. 5 indexed citations

17.

Tan, Daryl, Yvonne Loh, Hannah Jia Hui Ng, et al.. (2010). Attainment of at least a very good partial response after induction treatment is an important surrogate of longer survival for multiple myeloma. Bone Marrow Transplantation. 45(11). 1625–1630. 7 indexed citations

18.

Hwang, William Ying Khee, Claire Dearden, Yvonne Loh, et al.. (2009). Outpatient-Based Therapy of Oral Fludarabine and Subcutaneous Alemtuzumab for Asian Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia. Advances in Hematology. 2009. 1–4. 3 indexed citations

19.

Koh, Liang Piu, Yeow Tee Goh, Yeh Ching Linn, William Ying Khee Hwang, & Pearl Hock Neo Tan. (2000). Pseudomembranous Tracheobronchitis Caused by Aspergillus in a Patient after Peripheral Blood Stem Cell Transplantation. Annals of the Academy of Medicine Singapore. 29(4). 531–531. 10 indexed citations

20.

Linn, Yeh Ching, Yeow Tee Goh, & Hong Chang Tan. (2000). Relapse of Leukemia and Lymphoma after Marrow Transplant: A Review of Cases with Extramedullary Relapse. Leukemia & lymphoma. 38(1-2). 137–146. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact